Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
Every Certificate of Analysis we've ingested from verifiedpeptides.com, what each tests for, and what's missing. Sourced back to the original COA URLs — no hosting, no editorial.
Issues our data pipeline flagged on this vendor's COAs. Each flag points at a specific COA and the reason it was raised.
In our analysis, lot "KL04260380C" appears on 4 different peptides at Verified Peptides: bpc-157, bpc-157-tb-500, glow-blend, klow-blend. A lot number normally identifies a single manufacturing batch of one compound, so this pattern can indicate recycled lab data — or a vendor reusing one identifier across a multi-product shipment. Flagged from the COAs available to us; vendors may contest this.
Each row is one peptide. Columns show whether at least one COA from this vendor for that peptide tests for that property. Endotoxin and sterility are usually the gap.
| Peptide | COAs | Avg purity | HPLC | MS/MALDI | NMR | Endotoxin | Sterility | Metals | Microbial |
|---|---|---|---|---|---|---|---|---|---|
| 5-Amino 1-MQ | 2 | 98.40% | — | — |
Most recent batches we've ingested. Each row links to the original COA file as published by the vendor.
| Peptide | Lot | Lab | Purity | Tests | Tested | |
|---|---|---|---|---|---|---|
| Verified Peptide | — | Janoshik Analytical | 76.40% | LAL | — | View |
| Melanotan II | — | Janoshik Analytical | 99.31% | — | — | View |
| KPV | — | Janoshik Analytical | 99.60% | — | — | View |
How this is built: we discover every COA URL on the vendor's public testing page, fetch the file, run structured extraction, and persist what each COA actually tests for. Vendor copy isn't a signal — only the COAs themselves.
Full methodology →| — |
| — |
| 599-1 | 1 | 99.50% | — | — | — | — | — | — |
| 599-10 | 1 | 99.75% | — | — | — | — |
| 599-11 | 1 | 99.25% | — | — | — | — |
| 599-4 blue lyo | 1 | — | — | — | — | — | — |
| 599-5 | 1 | — | — | — | — | — | — |
| 599-7 | 1 | 97.60% | — | — | — | — |
| 615-1 | 1 | 99.80% | — | — | — | — |
| 615-5 | 1 | 97.90% | — | — | — | — | — | — |
| 615-7 | 1 | 99.90% | — | — | — | — |
| AOD-9604 | 6 | 99.43% | — | — | — | — |
| ARA-290 | 3 | 98.79% | — | — | — | — |
| BPC-157 | 55 | 98.61% | — | — |
| BPC-157 TB-500(TB4) | 13 | — | — | — | — |
| c615-10 | 1 | 96.90% | — | — | — | — |
| Cardiogen | 1 | 99.51% | — | — | — | — |
| Cartalax | 3 | 99.60% | — | — | — | — |
| CC-1295 (ipamorelin) | 1 | 99.58% | — | — | — | — |
| CJC-1295 DAC | 23 | 99.17% | — | — |
| DSIP | 6 | 99.58% | — | — | — | — |
| Epitalon | 15 | 99.51% | — | — |
| FOXO4-DRI | 2 | 99.58% | — | — | — | — |
| FOXO4-DRI | 1 | — | — | — | — | — | — |
| GHK-Cu | 22 | 99.78% | — |
| GHRP-6 | 2 | 99.62% | — | — | — | — |
| GLOW Blend | 7 | — | — | — | — | — | — |
| GLUTATHIONE | 3 | 98.99% | — | — | — | — |
| HGH Fragment | 1 | 99.80% | — | — | — |
| IGF-1 LR3 | 3 | 99.55% | — | — | — | — |
| Ipamorelin | 28 | 99.59% | — | — |
| Ipamorelin CJC-1295 No DAC | 5 | — | — | — | — | — | — |
| Kisspeptin-10 | 4 | 99.94% | — | — | — | — |
| Kissupetin-10 | 1 | 98.95% | — | — | — | — |
| KLOW Blend KPV GHK-Cu BPC157 TB500 | 2 | — | — | — | — | — |
| KPV | 8 | 99.75% | — | — | — |
| LL-37 | 4 | 98.25% | — | — | — | — |
| Melanotan I | 1 | 99.65% | — | — | — | — |
| Melanotan II | 2 | 99.61% | — | — | — | — |
| MOTSC | 22 | 99.53% | — | — |
| Mounjaro 5 | 4 | 91.57% | — | — | — | — |
| N-Acetyl Semax Amidate | 2 | 97.63% | — | — | — | — |
| NAD+ | 12 | — | — | — | — | — |
| P-21 | 1 | 98.58% | — | — | — | — |
| Pinealon | 5 | 94.92% | — | — | — | — |
| PROSTAMAX | 2 | 99.34% | — | — | — | — |
| PT-141 | 13 | 99.75% | — | — | — |
| S Amino 1MQ | 1 | 76.40% | — | — | — | — |
| Semaglutide | 14 | 99.77% | — | — | — |
| SNAP-8 | 7 | 99.72% | — | — | — | — |
| SS-31 | 7 | 99.86% | — | — | — | — |
| TB-500 | 33 | 98.76% | — | — |
| Tesamorelin | 4 | 99.67% | — | — | — | — |
| Testagen | 1 | 99.75% | — | — | — | — |
| TFA | 1 | — | — | — | — | — | — |
| Thymalin | 5 | 99.75% | — | — | — | — |
| Thymosin | 2 | 99.62% | — | — | — | — |
| Thymosin Alpha-1 | 8 | 99.67% | — | — | — | — |
| Thymulin | 1 | 99.42% | — | — | — | — |
| TTA | 1 | 99.50% | — | — | — | — |
| Verified Peptide | 2 | 76.40% | — | — | — | — |
| Vesugen | 1 | 99.27% | — | — | — | — |
| Vilon | 1 | 99.81% | — | — | — | — |
| VIP | 1 | 99.81% | — | — | — | — |
| Mounjaro 5 | — | Janoshik Analytical | 76.40% | LAL | — | View |
| S Amino 1MQ | — | Janoshik Analytical | 76.40% | LAL | — | View |
| GHK-Cu | — | Janoshik Analytical | 99.60% | LAL | — | View |
| MOTSC | — | Janoshik Analytical | 99.60% | LAL | — | View |
| KPV | — | Janoshik Analytical | 99.60% | MS | — | View |
| N-Acetyl Semax Amidate | — | Janoshik Analytical | 98.56% | — | — | View |
| PT-141 | — | Janoshik Analytical | 99.79% | — | 2026-06-30 | View |
| Kissupetin-10 | — | Janoshik Analytical | 98.95% | — | 2026-06-11 | View |
| SNAP-8 | SN806260510E | Janoshik Analytical | 99.80% | — | 2026-06-05 | View |
| FOXO4-DRI | FOX062602108 | Janoshik Analytical | 99.68% | — | 2026-06-05 | View |
| Tesamorelin | TM07261020J | Janoshik Analytical | 99.26% | — | 2026-06-05 | View |
| PROSTAMAX | PR006260320C | Janoshik Analytical | 99.02% | — | 2026-06-05 | View |
| GLUTATHIONE | GL0526031500B | Janoshik Analytical | 99.01% | — | 2026-06-05 | View |
| MOTS-C | M005261320L | Janoshik Analytical | 98.67% | — | 2026-06-05 | View |
| P-21 | P2106260210B | Janoshik Analytical | 98.58% | — | 2026-06-05 | View |
| Thymosin Alpha-1 | TA05260910H | Janoshik Analytical | 99.56% | LAL | 2026-06-01 | View |
| Cartalax | CAR0626042OD | Janoshik Analytical | 99.91% | LAL | 2026-05-29 | View |
| 5-Amino 1-MQ | 5AQ05260450D | Janoshik Analytical | — | LAL | 2026-05-28 | View |
| GLOW Blend | GL06260770F | Janoshik Analytical | — | — | 2026-05-27 | View |
| BPC-157 | BP06261310K | Janoshik Analytical | 99.78% | — | 2026-05-27 | View |
| Melanotan II | MT206260510E | Janoshik Analytical | 99.92% | LAL | 2026-05-26 | View |
| TB-500 | TB042609101 | Janoshik Analytical | 99.02% | LAL | 2026-05-13 | View |
| Ipamorelin | IPA05261110K | Janoshik Analytical | 99.84% | LAL | 2026-05-13 | View |
| Ipamorelin CJC-1295 No DAC | IPCJ05260920I | Janoshik Analytical | — | — | 2026-05-13 | View |
| BPC-157 | GL05260670E | Janoshik Analytical | — | LAL | 2026-05-13 | View |
| BPC-157 TB-500(TB4) | KL04260380C | Janoshik Analytical | — | LAL | 2026-05-13 | View |
| Ipamorelin | IPCJ052609201 | Janoshik Analytical | — | LAL | 2026-05-13 | View |
| LL-37 | LL05260305C | Janoshik Analytical | 99.64% | — | 2026-05-12 | View |
| TB-500 | FTB06260510E | Janoshik Analytical | 99.95% | MSLAL | 2026-05-12 | View |
| CJC-1295 DAC | CJD06261105J | Janoshik Analytical | 99.46% | LAL | 2026-05-12 | View |
| Frag(17-23) TB-500 | FTB0626Q510E | Janoshik Analytical | 99.95% | — | 2026-05-12 | View |
| KLOW KPV GHK-Cu BPC-157 TB-500(TB4) | KL04260380C | Janoshik Analytical | — | — | 2026-05-11 | View |
| BPC-157 | BP0526121OJ | Janoshik Analytical | 99.92% | — | 2026-05-11 | View |
| BPC-157 | BP05261210J | Janoshik Analytical | 99.92% | LAL | 2026-05-11 | View |
| BPC-157 | KL04260380C | Janoshik Analytical | — | LAL | 2026-05-11 | View |
| GLOW GHK-Cu BPC-157 TB-500(TB4) | GL05260670E | Janoshik Analytical | — | — | 2026-05-11 | View |
| Kisspeptin-10 | KIS04260310C | Janoshik Analytical | 99.94% | LAL | 2026-05-11 | View |
| Kisspeptin-10 | — | Janoshik Analytical | 99.94% | — | 2026-05-11 | View |
| PT-141 | PT03261310J | Janoshik Analytical | 99.78% | LAL | 2026-05-11 | View |
| LL-37 | — | Janoshik Analytical | 99.64% | — | 2026-05-09 | View |
| CJC-1295 DAC | — | Janoshik Analytical | 99.66% | — | 2026-05-05 | View |
| LL-37 | LL025602005C | Janoshik Analytical | 94.08% | — | 2026-05-05 | View |
| Frag(17-23) TB-500 | — | Janoshik Analytical | 99.96% | — | 2026-05-05 | View |
| TB-500 | FTB0626051OE | Janoshik Analytical | 99.95% | — | 2026-05-05 | View |
| KLOW RPY-GPK-Cu BPC-157 TB-500(TB4) | KLSL26036DC | Janoshik Analytical | — | — | 2026-04-30 | View |
| PT-141 | — | Janoshik Analytical | 99.77% | — | 2026-04-30 | View |
| Kisspeptin-10 | — | Janoshik Analytical | — | LAL | 2026-04-30 | View |